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Summary
The present study was undertaken to elucidate different requirements for CD2-mediated activation
of naive (CD45RO -) and memory (CD45RO+) CD4+ T cells. A mitogenic combination of
anti-CD2 (antiT112 and antiT113) mAbs could effectively induce the proliferation of memory
CD4+ T cells even in the absence of monocytes. In marked contrast, naive CD4+ T cells did
not disclose any proliferative responses to anti-CD2 mAbs, when monocytes were absent in culture.
This differential responsiveness of naive and memory CD4+ T cells appeared to be related largely
to a difference in I1,6-producing ability between both populations. I1r6 amongmonocyte-derived
cytokines could correct unresponsiveness of naive CD4+ T cells to anti-CD2 stimulation. Unlike
naive CD4+ T cells, memory CD4+ T cells produced IIr6 by themselves, with its mRNA being
expressed on anti-CD2 stimulation. Anti-IIr6RmAb significantly inhibited proliferation of memory
CD4+ T cells seen in the anti-CD2-stimulated cultures without monocytes, indicating the
involvement of their own production of Ilr6 in CD2-mediated activation. The results suggest
an essential role of 1176 for triggering of CD4+ T cells via the CD2 molecule.
T
he 50-kD CD2 molecule, originally defined as the sheep
erythrocyte receptor, is one of the earliest T cell differen-
tiation antigens to appear on developing thymocytes before
the stage of cell surface expression of TCR-CD3 (1, 2). In
addition to theTCRCD3 complex, a number of studies have
indicated that the CD2 molecule can serve to activate human
T cells (3-5). The cDNA encoding human CD2 has been
cloned and the predicted structure of CD2 reveals a trans-
membrane glycoproteln with a large cytoplasmic domain (126
amino acids), suggesting that it couldfunction in signal trans-
duction in T cells (6). More recently, lymphocyte function-
associated antigen-3 (LFA-3), which is expressed on a broad
spectrum of hematopoietic and nonhematopoietic cells, has
been identified as a natural ligand for CD2 in man (7) . It
has been demonstrated that acombination of mAbs directed
against two distinct epitopes of CD2, namely T112 and
T113, successfully triggers proliferation of and lymphokine
production by peripheral T cells (3, 8). Although the physi-
ological role of CD2 in thymic ontogeny or in immune re-
sponses has been proposed, the whole sequence of events in-
volved in T cell activation via CD2 is not clearly understood.
Recent studies have indicated that the naive and memory
cell populations within human T cells can be distinguished
phenotypically by surface markers (9-13) . Isoforms of CD45
(CD45RO or CD45RA) are useful markers for identification
ofboth populations. Expression ofCD45RO identifieshuman
memory T cells, while human naive T cells are confined to
the CD45RA+ subset. The results of studies using these
markers have disclosed some functional differences between
memory and naive T cells, including production ofcytokines
such as ID4 or IFN-y (10, 14), and CD3- or CD2-mediated
activation (15-17), in addition to a difference in responses
to recall antigens. In this report, we document a marked differ-
ence between naive (CD45RO - ) and memory (CD45RO+)
CD4+ T cells in responsiveness to anti-CD2 stimulation.
Memory CD4+ T cells were able to respond to a pair of
anti-CD2 mAbs (anti-T112 and anti-T113) to proliferate even
in the absence of monocytes, whereas any proliferative re-
sponses induced by anti-CD2 mAbs were not observed in
naive CD4+ T cells. The presence of monocytes in cultures
resulted in induction of anti-CD2-induced proliferation of
naive CD4+ T cells. It was significant that ID6 could cor-
rect unresponsiveness of naive CD4+ T cells to anti-CD2
stimulation. Unlike naive CD4+ T cells, memory CD4+ T
cells appeared to utilize their own producing ID6 for prolifer-
ation upon anti-CD2 stimulation. The results suggest an es-
sential role of II=6 in initiation of activation of CD4+ T cells
through the CD2 molecule.
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Cytokines.
￿
Human rIIr6was akind gift of Drs. T Hirano and
T Kishimoto (Osaka University, Osaka, Japan). Preparations of
rIL6 had a specific activity of 5 x 106 U/mg of protein, deter-
mined by the enhancement of IgM production by an EBV
transformed line (SKW6-C14 cells) (18). Human rIL1/3 (a gift of
Dr. Y. Hirai, Otsuka Pharmaceutical Co., Tokushima, Japan) had
a specific activity of 2 x 10'/mg of protein, estimated by the
mouse thymocyte proliferation assay. Human rIL2 was obtained
from Shionogi & Co. (Osaka, Japan) andhumanrTNF-a wasfrom
Suntory (Osaka, Japan).
Monoclonal Antibodies. Anti-CD2 mAbs, anti-T112 (IgG2a),
and antiT113 (IgG3) were kindly supplied in the ascites forms by
Dr. E. L. Reinherz (Dana Farber Cancer Institute, Boston, MA).
Two mAbs against human ILr6R, PMl (IgGI), andMT18 (IgG2b),
which have recently been developed(19),were generously provided
by Drs. T Taga andT. Kishimoto (Osaka University, Osaka, Japan).
One, PMl, inhibits the11,6-dependent cellular proliferation. The
other, MT18, is notblockedby 11,6 for its recognition of IL-6R;
therefore, it maybe suitable for immunostaining ofcells. AntiTac
mAb (IgG2a) against human IL2R (CD25) (20) was a kind gift
ofDr. T A. Waldmann (National Institutes of Health, Bethesda,
MD). The mAb UCHL1(IgG2a) against CD45RO (12) was pur-
chased from Dakopatts A/S (Copenhagen, Denmark). FITC-
conjugated anti-CD4 (anti-Leu-3a, IgGl) mAb was from Becton
DickinsonImmunocytometry Systems(Mountain View,CA). The
KNT4 mAb (IgG2a), which has been originally prepared as the
antibody against rIL2, but is not reactive with the natural form
of 11,2 (21), served as the control antibody.
Cell Preparation.
￿
PBMC were obtained from adult volunteers
between the ages of 25 and 32 yr by Ficoll-Hypaque density gra-
dientcentrifugation. E-rosetting T cellswere separatedfrom non-
rosettingcellsby rosetting with 2-aminoethylisothiouronium bro-
mide-treated SRBC, followedby Ficoll-Hypaque density gradient
centrifugation (22). After lysisof rosetted SRBC, Tcells from the
pellet were further depleted of contaminated monorytes by two
cycles ofplastic adherence.Subsequently, purifiedTcellswere stained
for CD45RO and CD4 by the two-color immunofluorescence
method, and separated into CD45RO - (naive) and CD45RO'
(memory) populations of CD4+ T cellsby using an Epics-C flow
cytometer(Coulter Electronics, Inc., Hialeah, FL)as described (23).
The resulting T cell populations contained <0.001% esterase-
positive monocytes. Adherent cells as thesource of monocyteswere
obtained from PBMC on plastic flasks andirradiated with 3,000rad.
Cell Cultures.
￿
The culture medium consisted of RPMI 1640
(Gibco Laboratories, GrandIsland, NY)containing 10% heat-inacti-
vated pooled human serum, 25 mM Hepes, 5 x 10-5 M 2-ME, 0.3
mg/ml L-glutamine, 200 U/ml penicillin G, and 10 Ag/ml gen-
tamicin. All cultures were set up in 96-well flat-bottomed plates
(Corning Glass Works, Corning, NY) in a final volume of 200
pl ofculture medium. Theplates were incubatedat 37°C in ahu-
midified atmosphere of 5% C02. For proliferative assays, the cells
were seeded at 3 x 10°/well and stimulated for 72 h with a com-
bination of anti-T112 and anti-T113 mAbs alone or together with
monorytes or cytokines. DNA synthesis was determined by
[3H]TdR incorporation (0.2 p,Ci/well, 6.7 Ci/mmol; New En-
gland Nuclear, Boston, MA) during the last 12 h of culture. In
some experiments, the cells were stimulated with 0.1% (vol/vol)
PHA-P (Difco Laboratories, Detroit, MI)and10 ng/mlPMA(Sigma
Chemical Co., St. Louis, MO) to evaluate induction of 11,6 ac-
tivity and IL6 mRNA by T cells. In addition,LPS (1 ug/ml;Difco
Laboratories) wasused to examinecontamination ofmonorytes/mac-
rophage lineage cells in isolated CD4' T cell populations. The
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cells were cultured at 1 x 105/well for determination of IL6
mRNA expression or 11,2 secretion and at 5 x 105/well for
demonstration of 11,6 activity in culture supernatants, as described
below.
IL2 Assay.
￿
IL2 was measured by the ability to support the
growth ofmurine 11,2-dependent CTLL2 cellsas describedprevi-
ously (24). 11,2 activity was evaluated by comparison with an
IL-2 standard preparation (Biological Response Modifiers [BRM]
standard).
11,6 Assay.
￿
IL-6 activity in culture supernatants wasdetermined
by acolorimetric assayusing an IL6-dependent murine hybridoma
clone, MH60.BSF2, as described elsewhere (25). 1 U of IL6 was
here arbitrarily defined by the amount required for 50% of the
maximal response of the hybridoma cells.
11,6 mRNA Analysis by Polymerase Chain Reaction.
￿
Expression
of 11,6 mRNA was evaluated by amplification using PCR as de-
scribed (26). CD4' T cell subpopulations were harvested after
12 h ofincubation in various culture conditions.Totalcellular RNA
was isolated by the acid guanidinium-phenol-chloroform method
(27), following the addition of 3 wg of yeast tRNA as a carrier
to harvestedcells. First strand DNA was synthesized at 42'C for
1 h in a final volume of 50 pl reaction mixture; RNA from 2 x
105 cells in 50 mM Tris-HCI, pH 8.3, 100 mM KCI, 10 mM
MgC12, 10 mM dithiothreitol, 1 mM each dNTP, 40 Wg/ml
oligo-dT (PharmaciaLKBBiotechnology, Bromma, Sweden), and
10 Uofreversetranscriptase (RAV2; Takara ShuzoCo., Ltd., Kyoto,
Japan). After incubation, the products were passed through
Sephadex G-50 spun column and were used as first strand cDNA
for PCR amplification.
85 pl ofPCR mixture was added to 5 pl of first strand cDNA.
PCR mixture contained 53.5 pl sterile water, 10 gl 10x reaction
buffer, 16 p.l ofdNTP mix (each at 1.25 mM), and 0.5 pl (2.5 U)
ofTaqpolymerase (Perkin-ElmerCetus, Norwalk, CT). PCRreac-
tion buffer (10x)contained500 mM KCI, 100mM Tris-HCI, pH
8.3, 20 MM MgC12, and 0.01% gelatin. 5 pl of each primer was
added to give a final concentration of 1 mM. The primers used
were ATGAACTCCTTCTCCACAAGC and CTACATTTGCC-
GAAGAGCCCTCAGandwere 594by apart(18). Amplifiedfrag-
ments of 639 by were thus expected. The mixture was subjected
to PCR amplificationusingaDNAThermalCycler (Perkin-Elmer
Cetus). Denaturation wasperformedat 94°C for1.5 min, annealing
at 55°C for 1.5 min, andprimer extension at 72'C for 2min. These
steps were repeated 30 times. 10 pl of each amplified product was
electrophoresedthrough 1.3% agarose gels to separate PCR frag-
ments, which were transferred to a nitrocellulose membrane and
hybridized with IL6 DNAprobe (providedby Drs. T Hirano and
T Kishimoto) labeled with digoxigenin (Boehringer Mannheim
Biochemicals, Indianapolis, IN). The Tagl-Xbal fragmentsof IL6
cDNA were used as a probe (18). The immunoenzymic detection
of hybridized DNA was performed according to a recommenda-
tion of the manufacturer.
Results and Discussion
A Marked Deference between Naive and Memory CD4+ T
Cells in Proliferative Responsiveness to Stimulation with Anti-CD2
mAbs. A mitogenic combination of anti-CD2 (anti-T112
and anti-T113) mAbs could stimulate effectively proliferation
of memory (CD45R0+) CD4+ T cells even in the absence
of monorytes (Fig. 1 B) . In marked contrast, naive
(CD45RO-) CD4+ T cells did not exhibit any discernible
proliferative responses in a wide range of anti-CD2 mAbs8
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Figure 1.
￿
Anti-CD2-induced proliferation of naive (A) and memory
(B) CD4+ T cells in the presence or absence of monocytes. Each CD4+
subpopulation was cultured (3 x 104/well) for 3 d with a combination
of anti-CD2 mAbs at various dilutions of ascitic fluids. 10% irradiated
monocytes were added at the beginning of culture. [3H]TdR incorpora-
tion was measured during the final 12 h of culture. Data are expressed
as the mean cpm of triplicate cultures.
examined, when monocytes were absent in culture (Fig. 1
A). Importantly, the addition of monocytes to the anti-
CD2-stimulated cultures of naive CD4+ T cells resulted in
induction of their proliferative responses at the levels com-
parable to those of memory CD4+ T cells. The restored re-
sponsiveness of naive CD4+ T cells to anti-CD2 mAbs was
inducibleby the addition of at least3% monocytes (datanot
shown). It should be noted that thedose-response curves for
anti-CD2 mAbs in proliferation of memory CD4+ T cells
were never shifted betweenthe presence andabsence of mono-
rytesin cultures. Theseresults indicatedthat, whilememory
CD4+ T cells might have the ability to respond to appro-
priate pairs of anti-CD2 mAbs by themselves, naive CD4+
T cells could be triggered by anti-CD2 stimulation to pro-
liferate with help of some signals provided by monocytes.
IL6 Corrects Unresponsiveness of Naive CD4+ T Cells in
CD2-mediated Triggering through IL2 Production. Generally,
activation of T cells in response to antigens, mitogens, or
antireceptor antibodies requires thepresence ofaccessorysignals
provided by the monoryte/macrophage lineage cells. These
accessory cells also provide costimulatory cytokines such as
IL1 for T cell stimulation, in addition to the promotion of
cell adhesion throughMHC-antigen complexes or othersur-
face molecules (28). In the present study we asked whether
some monoryte-derived cytokines might play the key role
for restoration of unresponsiveness of naive CD4+ T cells
to C132-mediated triggering. Theeffectsof threemajor prod-
ucts such as IL-10, TNF-a, and IL6 on C132-mediated acti-
vation of naive CD4+ T cells were examined in comparison
to those of monorytes or IL-2 as Tcell growth factors (Table
1). Favorable proliferation of naive CD4+ T cells was ob-
served in the anti-CD2-stimulated cultures with IL2 (1 ng/
ml). With respect to effects of monocyte-derived cytokines,
ILla did not induce the responsiveness of naive CD4+ T
cells to stimulation with anti-CD2 mAbs, although the mar-
ginal proliferation was observed at high doses (10 ng/ml) of
TNF-a. The most striking finding was that 11,6 could be
substituted seeminglyformonocytesin correction ofunrespon-
siveness of naive CD4+ T cells to anti-CD2 stimulation. As
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Table 1.
￿
Elects ofCytokines on Prolferative Responses of
Naive CD4+ T Cells to Anti-CD2 mAbs
Isolated naive CD4+ T cells (3 x 104/well) were cultured in the
presence of a combination of anti-T112 and anti-T113 mAbs (1/1,000
dilutions) for 3 d with or without monocytes or cytokines. [3H]TdR
incorporation was measured during thelast 12 h of cultureand expressed
as the mean cpm ± SEM of six donors.
shown in Fig. 2, dose-response studies for 11,6 showed that
the small amount of IL6 (0.1-0.3 ng/ml) was sufficient for
the induction of responsiveness of naive CD4+ T cells to
triggering via CD2. On the other hand, the cultures with
IL6 alone did not elicit the proliferation of naive CD4+ T
cells. As shown in Table 2, the presence of monorytes in
anti-CD2-stimulated cultures resulted in thesecretion of the
great amount ofIL2 in both naiveand memory populations.
It was shown that IL6, but neither IIAO nor TNF-a, in-
duced the release of IIr2 in naive CD4+ T cells stimulated
with anti-CD2 mAbs. These results suggested a major role
of IL-6 for anti-CD2-induced proliferation of naive CD4+
T cells corrected by the supplement of monocytes.
Autocrine SecretionandRequirement ofIL6for CD2-mediated
Activation ofMemory CD4+ T Cells. Recently, cDNA for
the human IL-6R has been cloned (29), and mAbs against
the human IL-6R have been developed using murine trans-
fectant cells expressing the human IL6R (19). Hirata et al.
(19), using anti-11,6R mAb, have demonstrated that IL6R is
Figure 2. Effect of various
doses of IL6 on proliferation of
naive CD4+ T cells in the pres-
ence or absence of anti-CD2
mAbs. Naive CD4+ T cells(3 x
104/well) were cultured for 3 d
with or without 1/1,000dilutions
of combined anti-CD2 mAbs at
various concentrations of IL6.
[3H]TdRincorporation was mea-
suredduring thefinal 12 hofcul-
ture. Data are expressed as the
iL-s (ngimi)
￿
mean cpm of triplicate cultures.
Anti-CD2 Additives Amount ['H]TdR incorporation
- None 424 ± 132
+ None 379 ± 110
+ Monocytes 10% 52,216 ± 3,930
+ IL-2 1 ng/ml 51,357 ± 4,129
+ IL-10 1 ng/ml 462 ± 82
+ IL-10 10 ng/ml 433 ± 128
+ TNF-a 1 ng/ml 621 ± 161
+ TNF-a 10 ng/ml 8,534 ± 290
+ IL-6 1 ng/ml 47,155± 1,632
+ IL-6 10 ng/ml 51,338 ± 3,425Table 2.
￿
IL-6 Induces IL-2 Secretion in Anti-CD2-stimulated
Naive CD4 + T Cells
CD4+ T subpopulations were incubated at a concentration of 5 x 105
cells/ml in the presence of anti -T112 and anti-T113 mAbs (1/1,000 di-
lution) with monocytes or cytokines . Culture supernatants were collected
after 36 h of incubation, and IL-2 activity was measured by the ability
to support the growth of CTLL-2 .
already expressed on unstimulated CD4` and CD8+ T cells,
although monocytes express much more IL-6R . From im-
munofluorescence analysis using an anti-IL-6R (MT18) mAb,
we found that theexpression ofIL6R was seen on both naive
and memory CD4+ T cells freshly isolated from the periph-
eral blood (data not shown) . Along with the finding that
1176 could correct unresponsiveness of naive CD4+ T cells
to anti-CD2 stimulation, the constitutive expression of IL
6R on memory as well as naive CD4+ cells seemed to imply
to us that IL-6 might operate in CD2-mediated activation
of memory CD4+ T cells in the cultures without mono-
cytes as well.
We used an IL-6-dependent murine hybridoma clone,
MH60.BSF2, to examineIL6 activity in culture supernatants
from memory and naive CD4+ T cells. Although PHA plus
PMA could promoteinductionof IL-6 activity by both naive
Table 3.
￿
Demonstration of IL-6 Activity in Supernatants
from Anti-CD2-stimulated Cultures ofMemory but not Naive
CD4+ T subpopulations were incubated at a concentration of 2.5 x
106 cells/ml with a combination of anti-T112 and anti-T113 mAbs
(1/500 dilutions) orPHA plus PMA . Culture supernatants were collected
after 36 hofincubation, and IL-6 activity was measured by the growth
of IL-6-dependent murine hybridoma clone, MH60.BSF2 .
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Figure 3.
￿
11,6 mRNA analyzed by PCR amplification. Naive (lanes
1-4) and memory (lanes 5-8) CD4' T cell populations were cultured
with various stimulants for 12 h. As described in Materials and Methods,
amplified products of 11,6mRNA were prepared, electrophoresed, trans-
ferred onto a nitrocellulose membrane, and hybridized with IIr6 cDNA .
The amount of applied samples of LPS-stimulated PBMC (lane 9) as a
control was equivalent to one-fifth of those of CD4' T cells. Stimulated
culture conditions are as follows . (Lanes 1 and 5) medium ; (lanes 2 and
6) anti-CD2 mAbs ; (lanes 3 and 7) LPS; (lanes 4 and 8) PHA plus PMA
(lane 9) PBMC stimulated with LPS .
and memory CD4+ T cells, there is a marked difference be-
tween both populations in their IIr6 production by anti-CD2
stimulation (Table 3) . Stimulation with a combination of anti-
T112 and T113 mAbs resulted in relatively low but substan-
tial levels of IL6 activity in supernatants from memory
CD4+ T cells . In contrast, IL-6 activity was negligible in
supernatants from anti-CD2-stimulated naive CD4+ T cells.
Furthermore, the expression of IL6 mRNA was examined
by the amplification method using PCR. Fig. 3 shows the
appreciable expression of 11,6 mRNA, apparently being ac-
companied by the IL6 secretion, in memory CD4+ T cells
stimulated with anti-CD2 mAbs, but not naive CD4+ T
cells . Although IL6 can be produced by a variety of cells,
includingT cells or B cells, monocytes are undoubtedly the
majorproducers in theperipheral blood (30) . Thus, it is pos-
sible that restricted production of 11,6 by memory CD4+
Table 4.
￿
Anti-IL-6R mAb Inhibits Proliferative Responses of
Memory CD4+ T Cells Induced by Anti-CD2 mAb in the
Absence of Monocytes
['H]TdR incorporation
Antibody
￿
Amount
￿
Exp. 1
￿
Exp. 2
￿
Exp. 3
Memory CD4+ T cells (3 x 104/well) were cultured in the presence
of anti-T112 and anti-T113 mAbs (1/1,000 dilutions) without added
monocytes for 3 d . Anti-IL-6R (PM1), anti-IL-2R (anti-Tac), or control
(KNT-4) mAbs were added at the beginning of the culture . [3H]TdR
incorporation was measured during thelast 12 h ofculture . Data represent
the means of triplicate cultures .
" Percent of the responses without the antibody shown in parentheses .
CD4+ T Cells
1tg/ml cpm
IL-6 activity None 27,083 19,154 38,654
Control 20 18,412 (68)' 18,154 (95) 32,612 (84)
Stimulation Naive CD4 + Memory CD4 +
Anti-IL-2R 20 491 (2) 1,286 (7) 1,564 (4)
U/ml
Anti-IL-6R 20 3,931 (15) 2,164 (11) 6,264 (16)
7 8,661 (32) 9,480 (49) 8,521 (22)
None <0.2 <0.2
3 17,747 (66) 12,156 (63) 25,403 (66)
Anti-CD2 <0.2 4.7 ± 1.2
PHA plus PMA 17 .3 ± 3 .8 30.9 ± 6.1
Stimuli Additives
IL-2 Produced (U/ml)
Naive CD4 + Memory CD4 +
None None <0.03 <0.03
Anti-CD2 None <0.03 0.48
Anti-CD2 Monocytes (10%) 15 .1 8 .2
Anti-CD2 IL-6 (1 ng/ml) 0.56 ND
Anti-CD2 IL-1,6 (i ng/ml) 0.06 ND
Anti-CD2 TNF-cx (1 ng/ml) 0.07 NDT cells might be due to some contamination of monocytes
in these cells. However, this possibility is unlikely, because
LPS, a potent stimulator for monocytes, which prompted 11,6
mRNA expression by unfractionated PBMC, did not induce
any band of IL-6 mRNA demonstrable by PCR technique
in the isolated memory CD4+ T cell population (Fig. 3).
To confirm directly that ILr6 produced by memory CD4+
T cells might be involved in theirinitiationofC132-mediated
activation, we finally examined whether anti-Ilr6R mAb
(PM1) with neutralizing ability couldinhibit proliferative re-
sponses of memory CD4+ T cells without monocytes to a
pair of anti-CD2 mAbs (Table 4). As can be expected, anti-
IL2R (antiTac) mAb abolished almost completely prolifera-
tive responses of memory CD4+ T cells seen in anti-CD2-
stimulated cultures without monocytes. Most importantly,
it was demonstrated that anti-IL6R (PM1) mAb exerted un-
equivocally inhibitory effects, though somewhat less than those
by anti-ILr2R, on anti-CD2-induced proliferation of memory
CD4+ T cells. Taken together, it appears that the differen-
tial responsiveness of naive and memory CD4+ T cells to
CD2-mediated triggering would be largely attributable to
a difference in ILr6-producing ability between both popu-
lations.
Earlier studies have indicated that activation of T cellsvia
the CD2 molecule, unlike stimulation with mitogens, an-
tigens, or antireceptor antibodies such as anti-CD3 or anti-
TCR mAbs, appears to be monocyte independent (3). Al-
though most studies on C132-mediated activation of T cells
havebeen done usingperipheral T cells that consist of a mix-
ture of naive and memory cells, a difference between naive
and memory T cells in proliferative responses to anti-CD2
antibodies has been reported from several laboratories (16,
17, 31). However, the results appear to be somewhat
conflicting. Consistent with the results of this work, some
studies have demonstrated enhanced responsiveness ofmemory
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